@article{4246ec110b734d16ad65cdad1aba3847,
title = "BMET-20RTOG1119 PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)",
author = "Kim, {In Ah.} and Winter, {Kathryn A.} and Peereboom, {David M.} and {De Los Santos}, {Jennifer F.} and Sperduto, {Paul W.} and White, {Julia R.} and Mehta, {Minesh P.}",
note = "Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2015.BACKGROUND: The addition of trastuzumab to cytotoxic chemotherapy has improved outcomes for patients with HER2 positive breast cancer. Increased survival coupled with limited blood-brain barrier (BBB) penetration of trastuzumab may contribute to the increased incidence of brain metastasis in these patients.",
year = "2015",
month = jan,
day = "11",
doi = "10.1093/neuonc/nov208.20",
language = "American English",
volume = "17",
journal = "Neuro-oncology",
}